Bio Solution Co.,Ltd. (KOSDAQ:086820)
4,525.00
-310.00 (-6.41%)
At close: Nov 16, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 116.76 billion as of November 16, 2026. It is the 25,762nd most valuable company in the world and the 1,103rd biggest in South Korea. Its market cap has decreased by 44.59% in one year.
Market Cap
116.76B
Enterprise Value
124.29B
Revenue
17.39B
Global Rank
Country Rank
#1,103 South Korea
PE Ratio
128.44
ChartMarket Cap Chart
Since August 20, 2018, Bio Solution's market cap has decreased from 218.31B to 116.76B, a decrease of -46.51%. That is a compound annual growth rate of -7.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 116.76B | -38.93% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 165.82B |
| Genome & Company | 164.74B |
| NIBEC | 146.31B |
| Y-Biologics | 134.77B |
| ISU Abxis | 131.09B |
| AriBioLab | 128.02B |
| Ensol Biosciences | 119.47B |
| Kanaph Therapeutics | 118.38B |